Related Experiment Video
Updated: Apr 28, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNA and gynecological reproductive diseases
Xavier Santamaria1, Hugh Taylor2
1Reproductive Medicine Department, Instituto Valenciano Infertilidad (IVI) Barcelona, Barcelona, Spain.
Abstract:
MicroRNAs (miRNAs) are a class of small non-coding RNAs estimated to regulate the translation of mRNAs in 30% of all genes in animals by inhibiting translation. Aberrant miRNA expression is associated with many human diseases, including gynecological diseases, cancer, inflammatory diseases, and cardiovascular disorders. Abnormal expression of miRNAs has been observed in multiple human reproductive tract diseases including preeclampsia, endometrioid endometrial adenocarcinoma, uterine leiomyomata, ovarian carcinoma, endometriosis, and recurrent pregnancy loss. In the following review, an update of the role of microRNA and gynecological diseases is performed covering, not only impact of microRNA dysregulation in the origin of each disease, but also showing the potential useful diagnostic and therapeutic tool that miRNA may play in these gynecological pathologies.
Insights
MicroRNAs (miRNAs) play a crucial role in gynecological diseases. Understanding miRNA dysregulation offers potential for new diagnostic and therapeutic strategies in women's reproductive health.
Area of Science:
- Molecular Biology
- Genetics
- Gynecology
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene translation in animals.
- Aberrant miRNA expression is linked to various diseases, including gynecological conditions.
- Specific reproductive tract diseases show abnormal miRNA expression patterns.
Purpose of the Study:
- To review the role of microRNAs in gynecological diseases.
- To detail the impact of miRNA dysregulation on disease origin.
- To explore miRNA's potential as diagnostic and therapeutic tools.
Main Methods:
- Literature review of studies on microRNAs and gynecological diseases.
- Analysis of miRNA dysregulation in conditions like preeclampsia, endometriosis, and cancer.
- Evaluation of current and future applications of miRNAs in diagnostics and therapeutics.
Main Results:
- MicroRNA dysregulation is implicated in the pathogenesis of numerous gynecological disorders.
- miRNAs are emerging as key players in the development of diseases such as ovarian carcinoma and endometriosis.
- Evidence suggests miRNAs can serve as biomarkers for early disease detection.
Conclusions:
- MicroRNA dysregulation significantly contributes to gynecological disease development.
- miRNAs hold promise as valuable diagnostic and therapeutic agents for gynecological pathologies.
- Further research into miRNA mechanisms can advance women's reproductive healthcare.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Microorganisms in Medicine and Therapeutics
Microbial Corrosion

